| BCYRN1 |
|
brain cytoplasmic RNA 1
|
|
|
0.666 |
0.423 |
| BTF3P11 |
|
basic transcription factor 3 pseudogene 11
|
|
|
0.519 |
0.731 |
| FRA16D |
|
fragile site, aphidicolin type, common, fra(16)(q23.2)
|
|
|
0.656 |
0.577 |
| HOXB@ |
|
homeobox B cluster
|
|
|
0.631 |
0.538 |
| HTC2 |
|
hypertrichosis 2 (generalized, congenital)
|
|
|
0.392 |
0.808 |
| MAA |
|
microphthalmia or anophthalmia and associated anomalies
|
|
|
0.666 |
0.577 |
| MT1JP |
|
metallothionein 1J, pseudogene
|
|
|
0.588 |
0.731 |
| NM |
|
neutrophil migration
|
|
|
0.473 |
0.808 |
| PTMAP4 |
|
prothymosin alpha pseudogene 4
|
|
|
0.638 |
0.731 |
| PVT1 |
|
Pvt1 oncogene
|
|
|
0.495 |
0.731 |
| RMRP |
|
RNA component of mitochondrial RNA processing endoribonuclease
|
|
|
0.519 |
0.731 |
| SNORD15A |
|
small nucleolar RNA, C/D box 15A
|
|
|
0.653 |
0.577 |
| SAI1 |
|
suppression of anchorage independence 1
|
|
|
0.560 |
0.615 |
| SSAV1 |
|
simian sarcoma-associated virus 1/gibbon ape leukemia virus-related endogenous retroviral element 1
|
|
|
0.695 |
0.269 |
| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| TERC |
|
telomerase RNA component
|
|
|
0.471 |
0.846 |
| TRE-TTC3-1 |
|
tRNA-Glu (anticodon TTC) 3-1
|
|
|
0.751 |
0.269 |
| XIST |
|
X inactive specific transcript
|
|
|
0.522 |
0.808 |
| LEPQTL1 |
|
Leptin, serum levels of
|
|
|
0.638 |
0.385 |
| SCLC1 |
|
small cell cancer of the lung
|
|
|
0.612 |
0.577 |
| CLLS2 |
|
Disrupted in B-cell neoplasia
|
|
|
0.678 |
0.346 |
| MLRL |
|
Myeloid leukemia-related gene (myeloid tumor suppressor)
|
|
|
0.564 |
0.769 |
| MYLKP1 |
|
myosin light chain kinase pseudogene 1
|
|
|
0.805 |
0.115 |
| CTPP |
|
Cataract, posterior polar
|
|
|
0.736 |
0.385 |
| MORF4 |
|
mortality factor 4 (pseudogene)
|
|
|
0.705 |
0.423 |